Liver Diseases Therapeutics Market 2027 By Type of Treatment, End user | The Insight Partners

Liver Diseases Therapeutics Market to 2027 - Global Analysis and Forecasts by Type of Treatment (Antiviral Drugs, Vaccines, Chemotherapy, Targeted Therapy, Immunosuppressant, Immunoglobulin's, Corticosteroids); End user (Hospitals, Adult Liver Disease Treatment Center, Ambulatory Surgical Center)

Report Code: TIPRE00004580 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Liver disease is either inherited (genetic) or is caused by factors that damage the liver, such as viruses (hepatitis A, hepatitis B, and hepatitis C) and alcohol use. Obesity is also associated with liver damage. The liver is essential in body for digestion of food and control the toxicity of substances in body. If not treated, damage to the liver results in scarring (cirrhosis), which can further lead to liver failure, a life-threatening condition.

MARKET DYNAMICS
The global liver diseases therapeutics market is expected to grow due to factors like in geriatric population, increasing prevalence of liver disease, government initiative of providing vaccines and growing awareness, change in lifestyle leads to increasing incidence of lifestyle related diseases, increase in consumption of alcohol and improper diet. As there is increase in geriatric population and increase in research and development activities by companies there are several opportunities for the market to grow.

MARKET SCOPE
The "Global Liver Diseases Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Liver Diseases Therapeutics Market with detailed market segmentation by type of treatment, end user and geography. The global Liver Diseases Therapeutics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Liver Diseases Therapeutics Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global liver diseases therapeutics market is segmented on the basis of type of treatment. Based on type of treatment, the market is segmented as antiviral drugs, vaccines, chemotherapy, targeted therapy, immunosuppressant, immunoglobulins, corticosteroids. Based on end user the market is segmented as hospitals, adult liver disease treatment center, and ambulatory surgical center.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Liver Diseases Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Liver Diseases Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Liver Diseases Therapeutics Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Liver Diseases Therapeutics Market in these regions.

MARKET PLAYERS
The reports cover key developments in the Liver Diseases Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Liver Diseases Therapeutics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Liver Diseases Therapeutics in the global market. Below mentioned is the list of few companies engaged in the Liver Diseases Therapeutics Market.

The report also includes the profiles of key Liver Diseases Therapeutics Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Bristol-Mayers Squibb
  • Gilead Sciences
  • GlaxoSmithKline plc.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Pfizer Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Liver Diseases Therapeutics Market - By Type of Treatment
1.3.2 Liver Diseases Therapeutics Market - By End user
1.3.3 Liver Diseases Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIVER DISEASES THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVER DISEASES THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LIVER DISEASES THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVER DISEASES THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. LIVER DISEASES THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LIVER DISEASES THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE OF TREATMENT
7.1. OVERVIEW
7.2. TYPE OF TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. ANTIVIRAL DRUGS
7.3.1. Overview
7.3.2. Antiviral Drugs Market Forecast and Analysis
7.4. VACCINES
7.4.1. Overview
7.4.2. Vaccines Market Forecast and Analysis
7.5. CHEMOTHERAPY
7.5.1. Overview
7.5.2. Chemotherapy Market Forecast and Analysis
7.6. TARGETED THERAPY
7.6.1. Overview
7.6.2. Targeted Therapy Market Forecast and Analysis
7.7. IMMUNOSUPPRESSANT
7.7.1. Overview
7.7.2. Immunosuppressant Market Forecast and Analysis
7.8. IMMUNOGLOBULINS
7.8.1. Overview
7.8.2. Immunoglobulins Market Forecast and Analysis
7.9. CORTICOSTEROIDS
7.9.1. Overview
7.9.2. Corticosteroids Market Forecast and Analysis
8. LIVER DISEASES THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. ADULT LIVER DISEASE TREATMENT CENTER
8.4.1. Overview
8.4.2. Adult Liver Disease Treatment Center Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTER
8.5.1. Overview
8.5.2. Ambulatory Surgical Center Market Forecast and Analysis
9. LIVER DISEASES THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Liver Diseases Therapeutics Market Overview
9.1.2 North America Liver Diseases Therapeutics Market Forecasts and Analysis
9.1.3 North America Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.1.4 North America Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.1.5 North America Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Liver Diseases Therapeutics Market
9.1.5.1.1 United States Liver Diseases Therapeutics Market by Type of Treatment
9.1.5.1.2 United States Liver Diseases Therapeutics Market by End user
9.1.5.2 Canada Liver Diseases Therapeutics Market
9.1.5.2.1 Canada Liver Diseases Therapeutics Market by Type of Treatment
9.1.5.2.2 Canada Liver Diseases Therapeutics Market by End user
9.1.5.3 Mexico Liver Diseases Therapeutics Market
9.1.5.3.1 Mexico Liver Diseases Therapeutics Market by Type of Treatment
9.1.5.3.2 Mexico Liver Diseases Therapeutics Market by End user
9.2. EUROPE
9.2.1 Europe Liver Diseases Therapeutics Market Overview
9.2.2 Europe Liver Diseases Therapeutics Market Forecasts and Analysis
9.2.3 Europe Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.2.4 Europe Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.2.5 Europe Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Liver Diseases Therapeutics Market
9.2.5.1.1 Germany Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.1.2 Germany Liver Diseases Therapeutics Market by End user
9.2.5.2 France Liver Diseases Therapeutics Market
9.2.5.2.1 France Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.2.2 France Liver Diseases Therapeutics Market by End user
9.2.5.3 Italy Liver Diseases Therapeutics Market
9.2.5.3.1 Italy Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.3.2 Italy Liver Diseases Therapeutics Market by End user
9.2.5.4 Spain Liver Diseases Therapeutics Market
9.2.5.4.1 Spain Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.4.2 Spain Liver Diseases Therapeutics Market by End user
9.2.5.5 United Kingdom Liver Diseases Therapeutics Market
9.2.5.5.1 United Kingdom Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.5.2 United Kingdom Liver Diseases Therapeutics Market by End user
9.2.5.6 Rest of Europe Liver Diseases Therapeutics Market
9.2.5.6.1 Rest of Europe Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.6.2 Rest of Europe Liver Diseases Therapeutics Market by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Liver Diseases Therapeutics Market Overview
9.3.2 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.3.4 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Liver Diseases Therapeutics Market
9.3.5.1.1 Australia Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.1.2 Australia Liver Diseases Therapeutics Market by End user
9.3.5.2 China Liver Diseases Therapeutics Market
9.3.5.2.1 China Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.2.2 China Liver Diseases Therapeutics Market by End user
9.3.5.3 India Liver Diseases Therapeutics Market
9.3.5.3.1 India Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.3.2 India Liver Diseases Therapeutics Market by End user
9.3.5.4 Japan Liver Diseases Therapeutics Market
9.3.5.4.1 Japan Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.4.2 Japan Liver Diseases Therapeutics Market by End user
9.3.5.5 South Korea Liver Diseases Therapeutics Market
9.3.5.5.1 South Korea Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.5.2 South Korea Liver Diseases Therapeutics Market by End user
9.3.5.6 Rest of Asia-Pacific Liver Diseases Therapeutics Market
9.3.5.6.1 Rest of Asia-Pacific Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.6.2 Rest of Asia-Pacific Liver Diseases Therapeutics Market by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Liver Diseases Therapeutics Market Overview
9.4.2 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.4.4 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Liver Diseases Therapeutics Market
9.4.5.1.1 South Africa Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.1.2 South Africa Liver Diseases Therapeutics Market by End user
9.4.5.2 Saudi Arabia Liver Diseases Therapeutics Market
9.4.5.2.1 Saudi Arabia Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.2.2 Saudi Arabia Liver Diseases Therapeutics Market by End user
9.4.5.3 U.A.E Liver Diseases Therapeutics Market
9.4.5.3.1 U.A.E Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.3.2 U.A.E Liver Diseases Therapeutics Market by End user
9.4.5.4 Rest of Middle East and Africa Liver Diseases Therapeutics Market
9.4.5.4.1 Rest of Middle East and Africa Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.4.2 Rest of Middle East and Africa Liver Diseases Therapeutics Market by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Liver Diseases Therapeutics Market Overview
9.5.2 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.5.4 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.5.5 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Liver Diseases Therapeutics Market
9.5.5.1.1 Brazil Liver Diseases Therapeutics Market by Type of Treatment
9.5.5.1.2 Brazil Liver Diseases Therapeutics Market by End user
9.5.5.2 Argentina Liver Diseases Therapeutics Market
9.5.5.2.1 Argentina Liver Diseases Therapeutics Market by Type of Treatment
9.5.5.2.2 Argentina Liver Diseases Therapeutics Market by End user
9.5.5.3 Rest of South and Central America Liver Diseases Therapeutics Market
9.5.5.3.1 Rest of South and Central America Liver Diseases Therapeutics Market by Type of Treatment
9.5.5.3.2 Rest of South and Central America Liver Diseases Therapeutics Market by End user
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LIVER DISEASES THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTELLAS PHARMA INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BRISTOL-MAYERS SQUIBB
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GILEAD SCIENCES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO., INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANOFI S.A.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PFIZER INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Astellas Pharma Inc.
3. Bristol-Mayers Squibb
4. Gilead Sciences
5. GlaxoSmithKline plc.
6. F. Hoffmann-La Roche Ltd.
7. Merck and Co., Inc.
8. Novartis AG
9. Sanofi S. A.
10. Pfizer Inc.